Literature DB >> 13430770

A new series of phenazines (rimino-compounds) with high antituberculosis activity.

V C BARRY, J G BELTON, M L CONALTY, J M DENNENY, D W EDWARD, J F O'SULLIVAN, D TWOMEY, F WINDER.   

Abstract

Entities:  

Keywords:  HETEROCYCLIC COMPOUNDS/effects; TUBERCULOSIS/experimental

Mesh：

Substances：

Year:  1957        PMID： 13430770     DOI： 10.1038/1791013a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  70 in total

1.  Uptake by reticulo-endothelial cells of the rimino-phenazine B.663(2-P-chloroanilino-5-P-chlorophenyl-3: 5-dihydro-3-isopropyliminophenazine).

Authors:  M L CONALTY; R D JACKSON
Journal:  Br J Exp Pathol       Date:  1962-12

2.  Further studies of the neutralization of silica toxicity in vitro.

Authors:  J MARKS
Journal:  Br J Ind Med       Date:  1959-04

Review 3.  New antituberculous drugs derived from natural products: current perspectives and issues in antituberculous drug development.

Authors:  Masayuki Igarashi; Yoshimasa Ishizaki; Yoshiaki Takahashi
Journal:  J Antibiot (Tokyo)       Date:  2017-11-01       Impact factor: 2.649

4.  Phagocytosed Clofazimine Biocrystals Can Modulate Innate Immune Signaling by Inhibiting TNFα and Boosting IL-1RA Secretion.

Authors:  Gi S Yoon; Sudha Sud; Rahul K Keswani; Jason Baik; Theodore J Standiford; Kathleen A Stringer; Gus R Rosania
Journal:  Mol Pharm       Date:  2015-06-05       Impact factor: 4.939

5.  Corneal changes in patients treated with clofazimine.

Authors:  P E Wålinder; L Gip; M Stempa
Journal:  Br J Ophthalmol       Date:  1976-07       Impact factor: 4.638

6.  Identification of novel mutations associated with clofazimine resistance in Mycobacterium tuberculosis.

Authors:  Shuo Zhang; Jiazhen Chen; Peng Cui; Wanliang Shi; Wenhong Zhang; Ying Zhang
Journal:  J Antimicrob Chemother       Date:  2015-06-04       Impact factor: 5.790

7.  Prooxidative activities of 10 phenazine derivatives relative to that of clofazimine.

Authors:  B M Zeis; R Anderson; J F O'Sullivan
Journal:  Antimicrob Agents Chemother       Date:  1987-05       Impact factor: 5.191

8.  Clofazimine shortens the duration of the first-line treatment regimen for experimental chemotherapy of tuberculosis.

Authors:  Sandeep Tyagi; Nicole C Ammerman; Si-Yang Li; John Adamson; Paul J Converse; Rosemary V Swanson; Deepak V Almeida; Jacques H Grosset
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-05       Impact factor: 11.205

9.  Elasticity in Macrophage-Synthesized Biocrystals.

Authors:  Elizabeth M Horstman; Rahul K Keswani; Benjamin A Frey; Phillip M Rzeczycki; Vernon LaLone; Jeffery A Bertke; Paul J A Kenis; Gus R Rosania
Journal:  Angew Chem Int Ed Engl       Date:  2017-01-12       Impact factor: 15.336

10.  Clofazimine for Treatment of Extensively Drug-Resistant Pulmonary Tuberculosis in China.

Authors:  Qingfeng Wang; Yu Pang; Wei Jing; Yufeng Liu; Na Wang; Hongyun Yin; Qing Zhang; Zhizhong Ye; Min Zhu; Fujian Li; Ping Liu; Tingting Wu; Wei Chen; Wei Wu; Zhihua Qin; Chao Qiu; Qunyi Deng; Tao Xu; Jing Wang; Ru Guo; Yadong Du; Jun Wang; Hairong Huang; Xiaohong Chen; Naihui Chu
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.